(Q31665544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Peter R. Flatt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M H Mooney

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C M Kelly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A M McKillop

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

95-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

The incretin concept today

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

On the treatment of diabetes mellitus with glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Biological activity of GLP-1-analogues with N-terminal modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

A synthetic glucagon-like peptide-1 analog with improved plasma stability

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Effects of Non-Glycated and Glycated Glucagon-Like Peptide-1(7-36) Amide on Glucose Metabolism in Isolated Mouse Abdominal Muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Determination of glucose by an automatic analyser

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel [...]

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Glycation of glucagon-like peptide-1(7-36)amide: characterization and impaired action on rat insulin secreting cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900125-7

7 January 2021

10.1016/S0167-0115(00)00125-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11111014%20AND%20SRC:MED&resulttype=core&format=json

release_svuyese22nf4zknb3hrpyalu7y

2 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/svuyese22nf4zknb3hrpyalu7y

24 November 2022

mapped directly with Wikidata item

1 reference